Related Experiment Videos
ETS1 suppresses tumorigenicity of human colon cancer cells
H Suzuki1, V Romano-Spica, T S Papas
1Laboratory of Molecular Oncology, National Cancer Institute, Frederick, MD 21702-1201, USA.
Abstract:
We have ectopically expressed transcription factor ETS1 in two different highly tumorigenic human colon cancer cell lines, DLD-1 and HCT116, that do not express endogenous ETS1 protein and have obtained several independent clones. The expression of wild-type ETS1 protein in these colon cancer cells reverses the transformed phenotype and tumorigenicity in a dose-dependent manner. By contrast, expression in DLD-1 cells of a variant form of ETS1, lacking transcriptional activity, did not alter the tumorigenic properties of the cells, suggesting that the reduction in tumorigenicity in these clones was specific for the wild-type ETS1 gene products. Since these colon cancer cells have multiple genetic alterations, the system described in this paper could be a good model to study the suppression of tumorigenicity at a transcriptional level, which could lead to the design and development of novel drugs for cancer treatment.
Insights
Ectopic expression of wild-type ETS1 in colon cancer cells reversed tumorigenicity. This suggests ETS1
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Colon cancer cell lines DLD-1 and HCT116 exhibit high tumorigenicity.
- These cell lines lack endogenous ETS1 protein expression.
Purpose of the Study:
- To investigate the effect of ectopic ETS1 expression on colon cancer cell tumorigenicity.
- To determine if wild-type ETS1's transcriptional activity is responsible for suppressing tumor growth.
Main Methods:
- Ectopic expression of wild-type ETS1 and a transcriptionally inactive variant in DLD-1 and HCT116 cells.
- Assessment of transformed phenotype and tumorigenicity in engineered cell clones.
Main Results:
- Wild-type ETS1 expression dose-dependently reversed the transformed phenotype and reduced tumorigenicity.
- A transcriptionally inactive ETS1 variant did not affect tumorigenic properties, indicating specificity of wild-type ETS1.
- Established clones serve as a model for studying transcriptional suppression of tumorigenicity.
Conclusions:
- Wild-type ETS1 functions as a tumor suppressor in colon cancer cells.
- The transcriptional activity of ETS1 is crucial for its tumor-suppressive effects.
- This research provides a foundation for developing novel cancer therapeutics targeting transcriptional mechanisms.